BIOMAT Database Logo BIOMAT Database Logo

Molecular Docking Studies and Synthesis of Amino-oxy-diarylquinoline Derivatives as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. 2019

Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Department of Chemistry, Laboratory of Organic Synthesis, Chulabhorn Research Institute, Laksi, Bangkok, Thailand.

In this study, amino-oxy-diarylquinolines were designed using structure-guided molecular hybridization strategy and fusing of the pharmacophore templates of nevirapine (NVP), efavirenz (EFV), etravirine (ETV, TMC125) and rilpivirine (RPV, TMC278). The anti-HIV-1 reverse transcriptase (RT) activity was evaluated using standard ELISA method, and the cytotoxic activity was performed using MTT and XTT assays. The primary bioassay results indicated that 2-amino-4-oxy-diarylquinolines possess moderate inhibitory properties against HIV-1 RT. Molecular docking results showed that 2-amino-4-oxy-diarylquinolines 8(A-D): interacted with the Lys101 and His235 residue though hydrogen bonding and interacted with Tyr318 residue though π-π stacking in HIV-1 RT. Furthermore, 8A: and 8D: were the most potent anti-HIV agents among the designed and synthesized compounds, and their inhibition rates were 34.0% and 39.7% at 1 µM concentration. Interestingly, 8A: was highly cytotoxicity against MOLT-3 (acute lymphoblastic leukemia), with an IC50 of 4.63±0.62 µg/mL, which was similar with that in EFV and TMC278 (IC50 7.76±0.37 and 1.57±0.20 µg/ml, respectively). Therefore, these analogs of the synthesized compounds can serve as excellent bases for the development of new anti-HIV-1 agents in the near future.

UI MeSH Term Description Entries
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011724 Pyridazines Six-membered rings with two adjacent nitrogen atoms also called 1,2-diazine.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068696 Rilpivirine A diarylpyrimidine derivative and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 that is used in the treatment of HIV INFECTIONS. It is also used in combination with other ANTI-HIV AGENTS, since ANTIVIRAL DRUG RESISTANCE emerges rapidly when it is used alone. R278474,Rilpivirine HCl,Rilpivirine Hydrochloride,TMC 278,TMC-278,TMC278,278, TMC,HCl, Rilpivirine,Hydrochloride, Rilpivirine
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors.
January 2020, Turkish journal of chemistry,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
August 2011, Bioorganic & medicinal chemistry,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 1).
December 2006, ChemMedChem,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
December 2006, ChemMedChem,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
June 2012, Bioorganic & medicinal chemistry,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Synthesis and SARs of indole-based α-amino acids as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
November 2014, Organic & biomolecular chemistry,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Docking of non-nucleoside inhibitors: neotripterifordin and its derivatives to HIV-1 reverse transcriptase.
December 2002, Proteins,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Synthesis, structure-activity relationships, and docking studies of N-phenylarylformamide derivatives (PAFAs) as non-nucleoside HIV reverse transcriptase inhibitors.
December 2012, European journal of medicinal chemistry,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Synthesis, molecular docking and biological evaluation of 2-(thiophen-2-yl)-1H-indoles as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
January 2020, Bioorganic chemistry,
Arthit Makarasen, and Mayuso Kuno, and Suwicha Patnin, and Nanthawan Reukngam, and Panita Khlaychan, and Sirinya Deeyohe, and Pakamas Intachote, and Busakorn Saimanee, and Suchada Sengsai, and Pornthip Boonsri, and Apinya Chaivisuthangkura, and Wandee Sirithana, and Supanna Techasakul
Docking-based 3D-QSAR analyses of pyrazole derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
April 2012, Journal of molecular modeling,
Copied contents to your clipboard!